16.64CHF+0.73%Mkt Cap: 289.54M $P/E: —Today
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Euro…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap289.54M $
Enterprise Value282.78M $
Revenue (TTM)88.09M $
Gross Profit17.32M $
Net Income (TTM)-56.19M $
Revenue/Share6.769 USD
Last Price16.64 CHF
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees93
CountryCH
SectorHealthcare
IndustryBiotechnology
ISINCH0027148649
Valuation
P/E (Trailing)—
P/E (Forward)95.53
PEG—
EV/EBITDA-7.62
EV/Revenue3.21
P/S3.21
P/B-18.41
EPS (TTM)-3.78
EPS (Forward)0.17
52W Range
9.38077% of range18.84
52W High18.84 CHF
52W Low9.380 CHF
Profitability
Gross Margin19.66%
Oper. Margin-4.08%
EBITDA Margin-42.15%
Profit Margin-63.79%
ROE416.69%
ROA-33.25%
Growth
Revenue Growth112.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-39.68M $
CapEx (TTM)59.35K $
FCF Margin-46.17%
FCF Yield-14.05%
Net Debt30.25M $
Net Debt/EBITDA-0.81
Balance Sheet
Debt/Equity-4.14
Current Ratio1.29
Quick Ratio0.78
Book Value/Sh-0.8820 CHF
Cash/Share1.675 CHF
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CHF
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateSep 8, 2022
Splits
Last Split1:10
Split DateJul 3, 2023
Analyst Consensus
Rating—
Target (Mean)27.50 CHF
Upside (mean)+65.3%
Target Range25.00 CHF – 30.00 CHF
CHF25.00+65.3% to meanCHF30.00
# Analysts2
Ownership
Shares Out.15.25M
Float11.27M
Insiders14.57%
Institutions11.10%
Technical
SMA 5015.40 (+8.0%)
SMA 20014.76 (+12.8%)
Beta-0.28
S&P 52W Chg18.16%
Avg Vol (30d)82.48K
Avg Vol (10d)96.11K
Technical Indicators
RSI (14)60.3
MACD0.3425
MACD Signal0.1236
MACD Hist.+0.2189
BB Upper17.12 CHF
BB Middle15.31 CHF
BB Lower13.50 CHF
BB Width23.63%
ATR (14)0.7299 CHF
Vol Ratio (20d)1.87x